Merck (MRK) Acquisitions (2009 - 2026)

Merck has disclosed Acquisitions across 15 years of filings, most recently posting $8.8 billion for Q1 2026.

• In Q1 2026, Acquisitions changed N/A year-over-year to $8.8 billion; the TTM figure through Mar 2026 stood at $18.8 billion (up 2622.92% YoY), while the FY2025 annual figure was $10.0 billion, changed N/A from the prior year.
• Acquisitions declined to $8.8 billion in Q1 2026, from $10.0 billion in the prior quarter.
• Over the last five years, Acquisitions for MRK reached as high as $10.0 billion in Q4 2025 and fell as low as -$1.3 billion in Q4 2024.
• The 4-year median for Acquisitions is $598.0 million (2024), against an average of $2.7 billion.
• The widest YoY moves for Acquisitions: up 12200.0% in 2022, down 234.44% in 2022.
• A 4-year view of Acquisitions shows it stood at -$121.0 million in 2022, then sank by 1010.74% to -$1.3 billion in 2024, then soared by 847.17% to $10.0 billion in 2025, then fell by 12.58% to $8.8 billion in 2026.
• According to Business Quant data, Acquisitions over the past three periods registered $8.8 billion, $10.0 billion, and -$1.3 billion for Q1 2026, Q4 2025, and Q4 2024 respectively.